Effect of platelet inhibition with cangrelor during PCI on ischemic events.

By Deepak L. Bhatt, Gregg Stone, K. Mahaffey, C. Gibson, P. Steg, C. Hamm, M. Price, S. Leonardi, D. Gallup, E. Bramucci and 14 more. New England Journal of Medicine, 2013

805 citations recorded by the source corpus.

Subfields: Cardiology and Cardiovascular Medicine, Surgery

View Paper: https://www.semanticscholar.org/paper/86ecb6771f62d920b8ca9d0f5feb45ee779351ae

How researchers see this paper

The researchers whose trusted networks rank it highest, strongest advocate first. Every researcher gets a different order.

1. E. Vandermeuelen
2. S. Kopp
3. T. Horlocker
4. W. Gogarten
5. L. Leffert
6. H. Benzon

Citations in the corpus

• Regional Anesthesia in the Patient Receiving Antithrombotic or Thrombolytic Therapy: American Society of Regional Anesthesia and Pain Medicine Evidence-Based Guidelines (Fourth Edition) (2018, methodology): “However, the CHAMPION PHOENIX trial, wherein the definition of myocardial infarction was based on the universal definition, showed superiority of the drug over clopidogrel in terms of reduction of periprocedural myocardial infarction with no difference in the incidence of severe bleeding between the”